ATXS
Price
$5.65
Change
-$0.11 (-1.91%)
Updated
Jun 25 closing price
Capitalization
318.85M
46 days until earnings call
KYMR
Price
$46.47
Change
-$0.67 (-1.42%)
Updated
Jun 25 closing price
Capitalization
3.03B
36 days until earnings call
Interact to see
Advertisement

ATXS vs KYMR

Header iconATXS vs KYMR Comparison
Open Charts ATXS vs KYMRBanner chart's image
Astria Therapeutics
Price$5.65
Change-$0.11 (-1.91%)
Volume$199.71K
Capitalization318.85M
Kymera Therapeutics
Price$46.47
Change-$0.67 (-1.42%)
Volume$861.48K
Capitalization3.03B
ATXS vs KYMR Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. KYMR commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and KYMR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ATXS: $5.65 vs. KYMR: $46.47)
Brand notoriety: ATXS and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 36% vs. KYMR: 100%
Market capitalization -- ATXS: $318.85M vs. KYMR: $3.03B
ATXS [@Biotechnology] is valued at $318.85M. KYMR’s [@Biotechnology] market capitalization is $3.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 2 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 6 bearish.
  • KYMR’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than KYMR.

Price Growth

ATXS (@Biotechnology) experienced а -4.07% price change this week, while KYMR (@Biotechnology) price change was +0.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +31.79%, and the average quarterly price growth was +15.79%.

Reported Earning Dates

ATXS is expected to report earnings on Aug 11, 2025.

KYMR is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.03B) has a higher market cap than ATXS($319M). KYMR YTD gains are higher at: 15.511 vs. ATXS (-36.801). ATXS has higher annual earnings (EBITDA): -124.4M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. ATXS (295M). ATXS has less debt than KYMR: ATXS (5.06M) vs KYMR (86.3M). KYMR has higher revenues than ATXS: KYMR (58.9M) vs ATXS (0).
ATXSKYMRATXS / KYMR
Capitalization319M3.03B11%
EBITDA-124.4M-232.67M53%
Gain YTD-36.80115.511-237%
P/E RatioN/AN/A-
Revenue058.9M-
Total Cash295M463M64%
Total Debt5.06M86.3M6%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSKYMR
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEMCX32.62N/A
N/A
JPMorgan Emerging Markets Equity C
RYHCX85.07N/A
N/A
Rydex Health Care C
PURYX55.36N/A
N/A
Putnam Research Y
FBSOX54.79N/A
N/A
Fidelity Select Enterprise Tech Svcs
EMEAX12.62N/A
N/A
Ashmore Emerging Markets Equity A